FDA approves ketamine-like drug to treat severe depression
The Food and Drug Administration on Tuesday approved Spravato, a nasal spray that is a close chemical relation to ketamine, for use by patients with severe depression that is hard to treat.
Ketamine is used as an anesthetic, as well as a recreational party drug — sometimes called "special K" — due to its ability to cause hallucinations. Spravato targets glutamate, which is believed to restore brain connections that help ease depression, The Associated Press reports. In a trial, patients who said the drug worked for them felt its effects almost immediately.
The FDA said Spravato will be used with an oral antidepressant, and because of the potential for abuse, patients must be under the supervision of a specialist who will monitor them for at least two hours after the spray is administered. This is the first new type of drug to treat depression to be approved since the launch of Prozac in 1988.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia is night editor for TheWeek.com. Her writing and reporting has appeared in Entertainment Weekly and EW.com, The New York Times, The Book of Jezebel, and other publications. A Southern California native, Catherine is a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Is there a peaceful way forward for Israel and Iran?
Today's Big Question Tehran has initially sought to downplay the latest Israeli missile strike on its territory
By Sorcha Bradley, The Week UK Published
-
The Week Unwrapped: Sudan, tackling homelessness and fake news
Podcast What is happening in Sudan? Could London really end rough sleeping? And why has Joe Lycett being making up stories?
By The Week Staff Published
-
Taylor Swift's surprise double album: an event of 'world-shaking proportions'
Why Everyone's Talking About Fans are 'reeling' after The Tortured Poets Department is followed by The Anthology – 15 additional tracks
By Julia O'Driscoll, The Week UK Published
-
Puffed rice and yoga: inside the collapsed tunnel where Indian workers await rescue
Speed Read Workers trapped in collapsed tunnel are suffering from dysentery and anxiety over their rescue
By Sorcha Bradley, The Week UK Published
-
More than 2,000 dead following massive earthquake in Morocco
Speed Read
By Justin Klawans Published
-
Mexico's next president will almost certainly be its 1st female president
Speed Read
By Peter Weber Published
-
North Korea's Kim to visit Putin in eastern Russia to discuss arms sales for Ukraine war, U.S. says
Speed Read
By Peter Weber Published
-
Gabon's military leader sworn in following coup in latest African uprising
Speed Read
By Justin Klawans Published
-
Nobody seems surprised Wagner's Prigozhin died under suspicious circumstances
Speed Read
By Peter Weber Published
-
Western mountain climbers allegedly left Pakistani porter to die on K2
Speed Read
By Justin Klawans Published
-
'Circular saw blades' divide controversial Rio Grande buoys installed by Texas governor
Speed Read
By Peter Weber Published